What We Do

Ceryx Medical was established in 2016 as a result of ground-breaking research at the Universities of Bath and Bristol.

Using revolutionary microchip technology, Ceryx Medical is collaborating with Auckland University in New Zealand to develop and trial a cardiac rhythm management device known as an enhanced cardiac pacemaker.

Ceryx’s device has the potential to be the world’s first curative therapy for heart failure and is expected to offer unprecedented efficiency and enhanced patient outcomes.

You can find out more about our work here or please email info@ceryxmedical.com for further details.